Undiagnosed HIV infection among New York City jail entrants, 2006: Results of a blinded serosurvey

Elizabeth M. Begier, Yussef Bennani, Lisa Forgione, Amado Punsalang, David B. Hanna, Jeffrey Herrera, Lucia Torian, Maria Gbur, Kent A. Sepkowitz, Farah Parvez

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

OBJECTIVE: Since 2004, when all New York City jail entrants began being offered rapid testing at medical intake, HIV testing has increased 4-fold. To guide further service improvement, we determined HIV prevalence among jail entrants, including proportion undiagnosed. Methods: Remnant serum from routine syphilis screening was salvaged for blinded HIV testing in 2006. Using HIV surveillance data and electronic clinical data, we ascertained previously diagnosed HIV infections before permanently removing identifiers. We defined "undiagnosed" as HIV-infected entrants who were unreported to surveillance and denied HIV infection. Results: Among the 6411 jail entrants tested (68.9% of admissions), HIV prevalence was 5.2% overall (males 4.7%; females: 9.8%). Adjusting for those not in the serosurvey, estimated seroprevalence is 8.7% overall (6.5% males, 14% females). Overall, 28.1% of HIV infections identified in the serosurvey were undiagnosed at jail entry; only 11.5% of these were diagnosed during routine jail testing. Few (11.1%) of the undiagnosed inmates reported injection drug use or being men who have sex with men. Conclusions: About 5%-9% of New York City jail entrants are HIV infected. Of the infected, 28% are undiagnosed; most of whom denied recognized HIV risk factors. To increase inmate's acceptance of routine testing, we are working to eliminate the required separate written consent for HIV testing to allow implementation of the Centers for Disease Control and Prevention-recommended opt out testing model.

Original languageEnglish (US)
Pages (from-to)93-101
Number of pages9
JournalJournal of Acquired Immune Deficiency Syndromes
Volume54
Issue number1
DOIs
StatePublished - May 2010
Externally publishedYes

Fingerprint

HIV Infections
HIV
Seroepidemiologic Studies
Syphilis
Centers for Disease Control and Prevention (U.S.)
Injections
Serum
Pharmaceutical Preparations

Keywords

  • HIV infections/diagnosis
  • HIV infections/epidemiology
  • Prevalence
  • Prisoners
  • Prisons

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Undiagnosed HIV infection among New York City jail entrants, 2006 : Results of a blinded serosurvey. / Begier, Elizabeth M.; Bennani, Yussef; Forgione, Lisa; Punsalang, Amado; Hanna, David B.; Herrera, Jeffrey; Torian, Lucia; Gbur, Maria; Sepkowitz, Kent A.; Parvez, Farah.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 54, No. 1, 05.2010, p. 93-101.

Research output: Contribution to journalArticle

Begier, EM, Bennani, Y, Forgione, L, Punsalang, A, Hanna, DB, Herrera, J, Torian, L, Gbur, M, Sepkowitz, KA & Parvez, F 2010, 'Undiagnosed HIV infection among New York City jail entrants, 2006: Results of a blinded serosurvey', Journal of Acquired Immune Deficiency Syndromes, vol. 54, no. 1, pp. 93-101. https://doi.org/10.1097/QAI.0b013e3181c98fa8
Begier, Elizabeth M. ; Bennani, Yussef ; Forgione, Lisa ; Punsalang, Amado ; Hanna, David B. ; Herrera, Jeffrey ; Torian, Lucia ; Gbur, Maria ; Sepkowitz, Kent A. ; Parvez, Farah. / Undiagnosed HIV infection among New York City jail entrants, 2006 : Results of a blinded serosurvey. In: Journal of Acquired Immune Deficiency Syndromes. 2010 ; Vol. 54, No. 1. pp. 93-101.
@article{ded320687e104d9f812c1edff9bd507e,
title = "Undiagnosed HIV infection among New York City jail entrants, 2006: Results of a blinded serosurvey",
abstract = "OBJECTIVE: Since 2004, when all New York City jail entrants began being offered rapid testing at medical intake, HIV testing has increased 4-fold. To guide further service improvement, we determined HIV prevalence among jail entrants, including proportion undiagnosed. Methods: Remnant serum from routine syphilis screening was salvaged for blinded HIV testing in 2006. Using HIV surveillance data and electronic clinical data, we ascertained previously diagnosed HIV infections before permanently removing identifiers. We defined {"}undiagnosed{"} as HIV-infected entrants who were unreported to surveillance and denied HIV infection. Results: Among the 6411 jail entrants tested (68.9{\%} of admissions), HIV prevalence was 5.2{\%} overall (males 4.7{\%}; females: 9.8{\%}). Adjusting for those not in the serosurvey, estimated seroprevalence is 8.7{\%} overall (6.5{\%} males, 14{\%} females). Overall, 28.1{\%} of HIV infections identified in the serosurvey were undiagnosed at jail entry; only 11.5{\%} of these were diagnosed during routine jail testing. Few (11.1{\%}) of the undiagnosed inmates reported injection drug use or being men who have sex with men. Conclusions: About 5{\%}-9{\%} of New York City jail entrants are HIV infected. Of the infected, 28{\%} are undiagnosed; most of whom denied recognized HIV risk factors. To increase inmate's acceptance of routine testing, we are working to eliminate the required separate written consent for HIV testing to allow implementation of the Centers for Disease Control and Prevention-recommended opt out testing model.",
keywords = "HIV infections/diagnosis, HIV infections/epidemiology, Prevalence, Prisoners, Prisons",
author = "Begier, {Elizabeth M.} and Yussef Bennani and Lisa Forgione and Amado Punsalang and Hanna, {David B.} and Jeffrey Herrera and Lucia Torian and Maria Gbur and Sepkowitz, {Kent A.} and Farah Parvez",
year = "2010",
month = "5",
doi = "10.1097/QAI.0b013e3181c98fa8",
language = "English (US)",
volume = "54",
pages = "93--101",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Undiagnosed HIV infection among New York City jail entrants, 2006

T2 - Results of a blinded serosurvey

AU - Begier, Elizabeth M.

AU - Bennani, Yussef

AU - Forgione, Lisa

AU - Punsalang, Amado

AU - Hanna, David B.

AU - Herrera, Jeffrey

AU - Torian, Lucia

AU - Gbur, Maria

AU - Sepkowitz, Kent A.

AU - Parvez, Farah

PY - 2010/5

Y1 - 2010/5

N2 - OBJECTIVE: Since 2004, when all New York City jail entrants began being offered rapid testing at medical intake, HIV testing has increased 4-fold. To guide further service improvement, we determined HIV prevalence among jail entrants, including proportion undiagnosed. Methods: Remnant serum from routine syphilis screening was salvaged for blinded HIV testing in 2006. Using HIV surveillance data and electronic clinical data, we ascertained previously diagnosed HIV infections before permanently removing identifiers. We defined "undiagnosed" as HIV-infected entrants who were unreported to surveillance and denied HIV infection. Results: Among the 6411 jail entrants tested (68.9% of admissions), HIV prevalence was 5.2% overall (males 4.7%; females: 9.8%). Adjusting for those not in the serosurvey, estimated seroprevalence is 8.7% overall (6.5% males, 14% females). Overall, 28.1% of HIV infections identified in the serosurvey were undiagnosed at jail entry; only 11.5% of these were diagnosed during routine jail testing. Few (11.1%) of the undiagnosed inmates reported injection drug use or being men who have sex with men. Conclusions: About 5%-9% of New York City jail entrants are HIV infected. Of the infected, 28% are undiagnosed; most of whom denied recognized HIV risk factors. To increase inmate's acceptance of routine testing, we are working to eliminate the required separate written consent for HIV testing to allow implementation of the Centers for Disease Control and Prevention-recommended opt out testing model.

AB - OBJECTIVE: Since 2004, when all New York City jail entrants began being offered rapid testing at medical intake, HIV testing has increased 4-fold. To guide further service improvement, we determined HIV prevalence among jail entrants, including proportion undiagnosed. Methods: Remnant serum from routine syphilis screening was salvaged for blinded HIV testing in 2006. Using HIV surveillance data and electronic clinical data, we ascertained previously diagnosed HIV infections before permanently removing identifiers. We defined "undiagnosed" as HIV-infected entrants who were unreported to surveillance and denied HIV infection. Results: Among the 6411 jail entrants tested (68.9% of admissions), HIV prevalence was 5.2% overall (males 4.7%; females: 9.8%). Adjusting for those not in the serosurvey, estimated seroprevalence is 8.7% overall (6.5% males, 14% females). Overall, 28.1% of HIV infections identified in the serosurvey were undiagnosed at jail entry; only 11.5% of these were diagnosed during routine jail testing. Few (11.1%) of the undiagnosed inmates reported injection drug use or being men who have sex with men. Conclusions: About 5%-9% of New York City jail entrants are HIV infected. Of the infected, 28% are undiagnosed; most of whom denied recognized HIV risk factors. To increase inmate's acceptance of routine testing, we are working to eliminate the required separate written consent for HIV testing to allow implementation of the Centers for Disease Control and Prevention-recommended opt out testing model.

KW - HIV infections/diagnosis

KW - HIV infections/epidemiology

KW - Prevalence

KW - Prisoners

KW - Prisons

UR - http://www.scopus.com/inward/record.url?scp=77951687984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951687984&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e3181c98fa8

DO - 10.1097/QAI.0b013e3181c98fa8

M3 - Article

C2 - 20042868

AN - SCOPUS:77951687984

VL - 54

SP - 93

EP - 101

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -